Login to Your Account

Astrazeneca partners with Cancer Research UK to find new targets

By Nuala Moran
Staff Writer

Monday, December 1, 2014
LONDON – Astrazeneca plc is extending its reach further into academic research in the UK, signing an agreement to give the medical charity Cancer Research UK (CRUK) access to its library of 2 million compounds and to a new screening facility currently under construction in Cambridge.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription